http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0248040-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6823 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 1986-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0248040-B1 |
| titleOfInvention | Ricin-antibody conjugates |
| abstract | A conjugate of ricin being whole ricin or a derivative of ricin, which derivative per se being inhibitory of protein synthesis in cell free systems, with an antibody which is preferentially absorbed by a tumour cell as compared to a non-tumour cell and wherein the galactose binding site of said ricin is blocked and pharmacologically acceptable salts thereof. |
| priorityDate | 1985-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.